The active implantable medical devices market size has grown strongly in recent years. It will grow from $27.95 billion in 2025 to $30.51 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to rising prevalence of cardiovascular and neurological disorders, early adoption of pacemakers and neurostimulators, advancements in battery technologies, improvements in implant biocompatibility, growing clinician familiarity with implantable systems.
The active implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $42.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expansion of remote patient monitoring solutions, rising demand for personalized implantable therapies, increasing integration of ai-enabled diagnostics, growth in aging population requiring chronic care, advancements in wireless power and communication technologies. Major trends in the forecast period include increasing integration of smart and connected implantable devices, rising adoption of miniaturized electronic components, growing use of data-driven therapeutic monitoring, expansion of long-term implantable therapies, enhanced focus on device longevity and reliability.
The active implantable medical devices market is poised for growth, driven by the increasing prevalence of cardiovascular diseases (CVD). Cardiovascular diseases encompass a range of conditions affecting the heart or blood vessels, often associated with factors such as atherosclerosis and an elevated risk of blood clots. Active implantable medical devices play a crucial role in regulating or monitoring irregular heartbeats in individuals with specific heart rhythm problems or heart failure. The surge in the incidence of cardiovascular diseases, notably due to the formation of fatty deposits and an increased risk of blood clots, is expected to propel the demand for active implantable medical devices. The rise in the geriatric population further contributes to this demand. For instance, in September 2025, according to the British Heart Foundation, a UK-based charity, over 7.6 million people in the UK - more than 4 million men and over 3.6 million women - are living with cardiovascular disease. Projections suggest that, driven by an aging population and improved survival rates, the number of individuals affected may increase by around 1 million by 2030 and by approximately 2 million by 2040. Therefore, the increase in cardiovascular diseases is driving the growth of the active implantable medical devices market.
Companies in the active implantable medical device market are also focused on developing technological advancements such as implantable PEEK filament to improve customization, enhance patient outcomes, and streamline production processes. Implantable PEEK filament is a specialized material created for making medical implants using additive manufacturing techniques. For instance, in March 2023, Invibio, a U.K.-based provider of high-performance implantable biomaterials, launched PEEK-OPTIMA AM filament. This filament is composed of implantable polyetheretherketone (PEEK) known for its biocompatibility and mechanical strength, making it ideal for implantable medical devices. The new filament is optimized for fused filament fabrication (FFF) and aims to enhance the production of medical devices, specifically designed for 3D printing applications in the medical field.
In December 2023, TekniPlex Healthcare, a U.S.-based manufacturer of medical device components, acquired Seisa Medical for an undisclosed amount. This acquisition allows TekniPlex to bolster its medical technology solutions platform, particularly in the minimally invasive and interventional therapy sectors. Seisa Medical is a U.S.-based manufacturer of active implantable medical devices.
Major companies operating in the active implantable medical devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co KG, LivaNova PLC, Cochlear Limited, MED‑EL Medical Electronics, Sonova Holding AG, NeuroPace Inc, NEVRO Corp, Axonics Inc, Aleva Neurotherapeutics SA, MicroTransponder Inc, Shree Pacetronix, Berlin Heart GmbH, Jarvik Heart Inc, Blackrock Neurotech, Nurotron Biotechnology Co Ltd, CARMAT SA, Precision Neuroscience, Pins Medical, Lepu Medical Technology Co Ltd, LifeTech Scientific.
North America was the largest region in the active implantable medical devices market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the active implantable medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the active implantable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the active implantable medical devices market by increasing costs of imported semiconductors, microelectronics, sensors, batteries, and precision manufacturing equipment. Manufacturers in North America and Europe are most affected due to complex global supply chains, while Asia-Pacific faces pricing pressure on exported implantable components. These tariffs are raising production costs and extending certification timelines. However, they are also driving localized electronics manufacturing, regional supplier partnerships, and innovation in cost-efficient implant design architectures.
The active implantable medical devices market research report is one of a series of new reports that provides active implantable medical devices market statistics, including active implantable medical devices industry global market size, regional shares, competitors with a active implantable medical devices market share, detailed active implantable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the active implantable medical devices industry. This active implantable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Active implantable medical devices (AIMDs) are entirely or partially embedded medical tools intended for diagnostic or therapeutic purposes, engineered to be permanently positioned within the human body.
These devices encompass a range of products including cardiac pacemakers, implantable cardioverter defibrillators (ICDs), nerve stimulators, cochlear implants, ventricular assist devices, among others. For instance, an implantable cardioverter-defibrillator (ICD) is a small, battery-powered device inserted into the chest to detect and regulate abnormal heart rhythms. They serve diverse applications such as cardiovascular, neurological treatments, aiding hearing impairment, and are employed by various end-users including hospitals, specialized clinics, and ambulatory surgical centers.
The active implanted medical devices market consists of sales of active implanted medical devices with components such as battery packs, controllers, implant kits, leads, programmers, and refill kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The active implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $42.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expansion of remote patient monitoring solutions, rising demand for personalized implantable therapies, increasing integration of ai-enabled diagnostics, growth in aging population requiring chronic care, advancements in wireless power and communication technologies. Major trends in the forecast period include increasing integration of smart and connected implantable devices, rising adoption of miniaturized electronic components, growing use of data-driven therapeutic monitoring, expansion of long-term implantable therapies, enhanced focus on device longevity and reliability.
The active implantable medical devices market is poised for growth, driven by the increasing prevalence of cardiovascular diseases (CVD). Cardiovascular diseases encompass a range of conditions affecting the heart or blood vessels, often associated with factors such as atherosclerosis and an elevated risk of blood clots. Active implantable medical devices play a crucial role in regulating or monitoring irregular heartbeats in individuals with specific heart rhythm problems or heart failure. The surge in the incidence of cardiovascular diseases, notably due to the formation of fatty deposits and an increased risk of blood clots, is expected to propel the demand for active implantable medical devices. The rise in the geriatric population further contributes to this demand. For instance, in September 2025, according to the British Heart Foundation, a UK-based charity, over 7.6 million people in the UK - more than 4 million men and over 3.6 million women - are living with cardiovascular disease. Projections suggest that, driven by an aging population and improved survival rates, the number of individuals affected may increase by around 1 million by 2030 and by approximately 2 million by 2040. Therefore, the increase in cardiovascular diseases is driving the growth of the active implantable medical devices market.
Companies in the active implantable medical device market are also focused on developing technological advancements such as implantable PEEK filament to improve customization, enhance patient outcomes, and streamline production processes. Implantable PEEK filament is a specialized material created for making medical implants using additive manufacturing techniques. For instance, in March 2023, Invibio, a U.K.-based provider of high-performance implantable biomaterials, launched PEEK-OPTIMA AM filament. This filament is composed of implantable polyetheretherketone (PEEK) known for its biocompatibility and mechanical strength, making it ideal for implantable medical devices. The new filament is optimized for fused filament fabrication (FFF) and aims to enhance the production of medical devices, specifically designed for 3D printing applications in the medical field.
In December 2023, TekniPlex Healthcare, a U.S.-based manufacturer of medical device components, acquired Seisa Medical for an undisclosed amount. This acquisition allows TekniPlex to bolster its medical technology solutions platform, particularly in the minimally invasive and interventional therapy sectors. Seisa Medical is a U.S.-based manufacturer of active implantable medical devices.
Major companies operating in the active implantable medical devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co KG, LivaNova PLC, Cochlear Limited, MED‑EL Medical Electronics, Sonova Holding AG, NeuroPace Inc, NEVRO Corp, Axonics Inc, Aleva Neurotherapeutics SA, MicroTransponder Inc, Shree Pacetronix, Berlin Heart GmbH, Jarvik Heart Inc, Blackrock Neurotech, Nurotron Biotechnology Co Ltd, CARMAT SA, Precision Neuroscience, Pins Medical, Lepu Medical Technology Co Ltd, LifeTech Scientific.
North America was the largest region in the active implantable medical devices market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the active implantable medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the active implantable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the active implantable medical devices market by increasing costs of imported semiconductors, microelectronics, sensors, batteries, and precision manufacturing equipment. Manufacturers in North America and Europe are most affected due to complex global supply chains, while Asia-Pacific faces pricing pressure on exported implantable components. These tariffs are raising production costs and extending certification timelines. However, they are also driving localized electronics manufacturing, regional supplier partnerships, and innovation in cost-efficient implant design architectures.
The active implantable medical devices market research report is one of a series of new reports that provides active implantable medical devices market statistics, including active implantable medical devices industry global market size, regional shares, competitors with a active implantable medical devices market share, detailed active implantable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the active implantable medical devices industry. This active implantable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Active implantable medical devices (AIMDs) are entirely or partially embedded medical tools intended for diagnostic or therapeutic purposes, engineered to be permanently positioned within the human body.
These devices encompass a range of products including cardiac pacemakers, implantable cardioverter defibrillators (ICDs), nerve stimulators, cochlear implants, ventricular assist devices, among others. For instance, an implantable cardioverter-defibrillator (ICD) is a small, battery-powered device inserted into the chest to detect and regulate abnormal heart rhythms. They serve diverse applications such as cardiovascular, neurological treatments, aiding hearing impairment, and are employed by various end-users including hospitals, specialized clinics, and ambulatory surgical centers.
The active implanted medical devices market consists of sales of active implanted medical devices with components such as battery packs, controllers, implant kits, leads, programmers, and refill kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Active Implantable Medical Devices Market Characteristics
3. Active Implantable Medical Devices Market Supply Chain Analysis
4. Global Active Implantable Medical Devices Market Trends and Strategies
5. Active Implantable Medical Devices Market Analysis of End Use Industries
7. Global Active Implantable Medical Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Active Implantable Medical Devices Total Addressable Market (TAM) Analysis for the Market
9. Active Implantable Medical Devices Market Segmentation
10. Active Implantable Medical Devices Market Regional and Country Analysis
11. Asia-Pacific Active Implantable Medical Devices Market
12. China Active Implantable Medical Devices Market
13. India Active Implantable Medical Devices Market
14. Japan Active Implantable Medical Devices Market
15. Australia Active Implantable Medical Devices Market
16. Indonesia Active Implantable Medical Devices Market
17. South Korea Active Implantable Medical Devices Market
18. Taiwan Active Implantable Medical Devices Market
19. South East Asia Active Implantable Medical Devices Market
20. Western Europe Active Implantable Medical Devices Market
21. UK Active Implantable Medical Devices Market
22. Germany Active Implantable Medical Devices Market
23. France Active Implantable Medical Devices Market
24. Italy Active Implantable Medical Devices Market
25. Spain Active Implantable Medical Devices Market
26. Eastern Europe Active Implantable Medical Devices Market
27. Russia Active Implantable Medical Devices Market
28. North America Active Implantable Medical Devices Market
29. USA Active Implantable Medical Devices Market
30. Canada Active Implantable Medical Devices Market
31. South America Active Implantable Medical Devices Market
32. Brazil Active Implantable Medical Devices Market
33. Middle East Active Implantable Medical Devices Market
34. Africa Active Implantable Medical Devices Market
36. Active Implantable Medical Devices Market Competitive Landscape and Company Profiles
37. Active Implantable Medical Devices Market Other Major and Innovative Companies
40. Active Implantable Medical Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Active Implantable Medical Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses active implantable medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for active implantable medical devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The active implantable medical devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Cardiac Pacemakers; Implantable Cardioverter Defibrillators (ICD); Nerve Simulators; Cochlear Implants; Ventricular Assist Devices; Other Products2) By Application: Cardiovascular; Neurological; Hearing Impairment; Other Applications
3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers
Subsegments:
1) By Cardiac Pacemakers: Single Chamber Pacemakers; Dual Chamber Pacemakers; Biventricular Pacemakers2) By Implantable Cardioverter Defibrillators (ICD): Transvenous ICDs; Subcutaneous ICDs
3) By Nerve Stimulators: Spinal Cord Stimulators; Peripheral Nerve Stimulators; Deep Brain Stimulators
4) By Cochlear Implants: Single-Electrode Cochlear Implants; Multichannel Cochlear Implants
5) By Ventricular Assist Devices: Left Ventricular Assist Devices (LVAD); Right Ventricular Assist Devices (RVAD); Bi-Ventricular Assist Devices (BiVAD)
6) By Other Products: Neurostimulators for Pain Management; Implantable Drug Delivery Systems; Implantable Blood Pressure Monitors
Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; BIOTRONIK SE & Co KG; LivaNova PLC; Cochlear Limited; MED‑EL Medical Electronics; Sonova Holding AG; NeuroPace Inc; NEVRO Corp; Axonics Inc; Aleva Neurotherapeutics SA; MicroTransponder Inc; Shree Pacetronix; Berlin Heart GmbH; Jarvik Heart Inc; Blackrock Neurotech; Nurotron Biotechnology Co Ltd; CARMAT SA; Precision Neuroscience; Pins Medical; Lepu Medical Technology Co Ltd; LifeTech Scientific
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Active Implantable Medical Devices market report include:- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- BIOTRONIK SE & Co KG
- LivaNova PLC
- Cochlear Limited
- MED‑EL Medical Electronics
- Sonova Holding AG
- NeuroPace Inc
- NEVRO Corp
- Axonics Inc
- Aleva Neurotherapeutics SA
- MicroTransponder Inc
- Shree Pacetronix
- Berlin Heart GmbH
- Jarvik Heart Inc
- Blackrock Neurotech
- Nurotron Biotechnology Co Ltd
- CARMAT SA
- Precision Neuroscience
- Pins Medical
- Lepu Medical Technology Co Ltd
- LifeTech Scientific
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 30.51 Billion |
| Forecasted Market Value ( USD | $ 42.81 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
